Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | CAPN1 | P07384 | 5/20 | 0.50 |
| ▸ | CAPN9 | O14815 | 1/20 | 0.50 |
| ▸ | CTSB | P07858 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | PSMB1 | P20618 | 1/20 | 0.48 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.48 |
| ▸ | PSMB2 | P49721 | 1/20 | 0.48 |
| ▸ | MMP2 | P08253 | 1/20 | 0.46 |
| ▸ | F10 | P00742 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | MMP8 | P22894 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7762733 | 1.00 | KMT2A (0.54) | KMT2ACAPN1CAPN9CTSBMAPK1 | |
| SCHEMBL8348444 | 1.00 | KMT2A (0.54) | KMT2ACAPN1CAPN9CTSBMAPK1 | |
| SCHEMBL7207278 | 1.00 | KMT2A (0.54) | KMT2ACAPN1CAPN9CTSBMAPK1 | |
| SCHEMBL8343183 | 1.00 | KMT2A (0.54) | KMT2ACAPN1CAPN9CTSBMAPK1 | |
| SCHEMBL7762722 | 1.00 | KMT2A (0.54) | KMT2ACAPN1CAPN9CTSBMAPK1 | |
| SCHEMBL9089190 | 0.89 | CAPN1 (0.49) | KMT2ACAPN1CAPN9CTSBMAPK1 | |
| SCHEMBL7206727 | 0.89 | L3MBTL1 (0.59) | CAPN1CAPN9CTSBMAPK1MMP2 | |
| SCHEMBL7206720 | 0.89 | L3MBTL1 (0.59) | CAPN1CAPN9CTSBMAPK1MMP2 | |
| SCHEMBL8349149 | 0.89 | L3MBTL1 (0.59) | CAPN1CAPN9CTSBMAPK1MMP2 | |
| SCHEMBL7762727 | 0.88 | FCER2 (0.56) | CAPN1PSMB5MMP8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0921122-B1 | EPOXYSUCCINAMIDE DERIVATIVES OR SALTS THEREOF | TAIHO PHARMACEUTICAL CO LTD (JP) | 2003-05-21 | — | — | EP | disclosed |
| EP-0808839-B1 | EPOXYSUCCINAMIDE DERIVATIVES OR SALTS THEREOF, AND DRUGS CONTAINING THE SAME | TAIHO PHARMACEUTICAL CO LTD (JP) | 2001-05-23 | — | — | EP | disclosed |
| US-6110967-A | USEFUL AS AGENTS FOR PREVENTING AND TREATING METABOLIC OSTEOPATHY SUCH AS OSTEOPOROSIS, HYPERCALCEMIA AND BONE METASTASIS OF CANCER BECAUSE THEY SPECIFICALLY INHIBITS CATHEPSIN L AND ITS FAMILY ENZYMES TO INHIBIT BONE RESORPTION | TAIHO PHARMACEUTICALS CO., LTD. (JP) | 2000-08-29 | — | — | US | disclosed |
| EP-0921122-A1 | NOVEL EPOXYSUCCINAMIDE DERIVATIVES OR SALTS THEREOF | TAIHO PHARMACEUTICAL COMPANY, LIMITED (JP) | 1999-06-09 | — | — | EP | disclosed |
| EP-0808839-A1 | EPOXYSUCCINAMIDE DERIVATIVES OR SALTS THEREOF, AND DRUGS CONTAINING THE SAME | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 1997-11-26 | — | — | EP | disclosed |